Mukherjee J J, Islam N, Kaltsas G, Lowe D G, Charlesworth M, Afshar F, Trainer P J, Monson J P, Besser G M, Grossman A B
Department of Endocrinology, St. Bartholomew's Hospital, London, United Kingdom.
J Clin Endocrinol Metab. 1997 Jul;82(7):2357-62. doi: 10.1210/jcem.82.7.4043.
Rathke's cleft cysts are cystic sellar and suprasellar lesions, characteristically lined by a single layer of ciliated cuboidal or columnar epithelium. In contrast, craniopharyngiomass, which are also cystic sellar and suprasellar lesions, are characteristically lined by stratified squamous epithelium with keratinization on a layer of connective tissue. The usual management recommended for Rathke's cleft cysts is simple surgical drainage with partial excision of the cyst wall. Recurrences of these cysts reportedly have been very rare. This retrospective study presents the details of 12 patients (6 females; median age 30 yr, range 21-58 yr) with Rathke's cleft cyst, referred to our department over a 15-yr period (1981-1996), an unusual feature being the recurrence of 4 (33%) of these lesions. Clinical, endocrine, radiological, surgical (10 transsphenoidal; 2 transcranial), and pathological details were recorded. Nine out of 12 patients (75%) were symptomatic; visual symptoms were the commonest, and 8 had visual field defects. The median duration of symptoms was 12 months (range 3-24 months). Three patients (25%) had panhypopituitarism, 2 of whom also had diabetes insipidus (17%). The cysts varied in size from 6 mm to 50 mm, 1 being entirely suprasellar. There were no pathognomonic clinical or radiological features to differentiate them from other pituitary lesions, although the presence of diabetes insipidus in 2 patients suggested that the lesion was not a pituitary adenoma. A definite histological diagnosis was possible in 8 patients; in 4, the diagnosis was presumptive. The median duration of follow-up was 30 months (1-168 months). Four patients (33%) showed reexpansion at 3, 6, 48, and 48 months after initial surgery, 3 of whom were symptomatic and required repeat surgery. Two of these patients were given postoperative external beam pituitary radiotherapy. Apparent recurrence of Rathke's cleft cysts after initially successful surgery in our series was higher than suggested by previous reports, and thus, long-term follow-up with pituitary imaging and neuroophthalmological assessment is essential. There are no specific characteristics of the cyst that predict recurrence. Ideal management of these cysts is unclear, but aspiration, followed by extensive excision of the cyst wall when possible, seems to be the best initial option. For recurrent symptomatic tumors, surgical resection is the treatment of choice. Considering the high recurrence rate with residual structural and functional dysfunction, the role of radiotherapy in preventing recurrence of these cysts needs careful evaluation with a larger study with a longer follow-up period.
拉克氏裂囊肿是鞍内和鞍上的囊性病变,其特征是内衬单层纤毛立方上皮或柱状上皮。相比之下,颅咽管瘤同样是鞍内和鞍上的囊性病变,其特征是在一层结缔组织上内衬有角化的复层鳞状上皮。拉克氏裂囊肿通常推荐的治疗方法是简单的手术引流并部分切除囊肿壁。据报道,这些囊肿的复发非常罕见。这项回顾性研究呈现了15年间(1981 - 1996年)转诊至我科的12例拉克氏裂囊肿患者(6例女性;中位年龄30岁,范围21 - 58岁)的详细情况,一个不寻常的特征是这些病变中有4例(33%)复发。记录了临床、内分泌、放射学、手术(10例经蝶窦;2例经颅)及病理细节。12例患者中有9例(75%)有症状;视觉症状最为常见,8例有视野缺损。症状的中位持续时间为12个月(范围3 - 24个月)。3例患者(25%)有全垂体功能减退,其中2例还患有尿崩症(17%)。囊肿大小从6毫米至50毫米不等,1例完全位于鞍上。尽管2例患者存在尿崩症提示病变不是垂体腺瘤,但没有可将其与其他垂体病变相鉴别的特征性临床或放射学表现。8例患者可获得明确的组织学诊断;4例诊断为推测性。中位随访时间为30个月(1 - 168个月)。4例患者(占33%)在初次手术后3个月、6个月、48个月和48个月出现复发,其中3例有症状并需要再次手术。其中2例患者术后接受了垂体外照射放疗。在我们的系列研究中,拉克氏裂囊肿初次手术成功后明显复发的情况高于既往报道,因此,对垂体进行影像学检查和神经眼科评估的长期随访至关重要。囊肿没有预测复发的特定特征。这些囊肿的理想治疗方法尚不清楚,但抽吸,然后尽可能广泛地切除囊肿壁似乎是最佳的初始选择。对于复发性有症状肿瘤,手术切除是首选治疗方法。考虑到复发率高且存在残余结构和功能障碍,放疗在预防这些囊肿复发中的作用需要通过一项随访期更长的更大规模研究进行仔细评估。